UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$456M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$403M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$391M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$381M |
| 5 |
UnitedHealth
UNH
|
+$355M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$3.79B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$626M |
| 3 |
Microsoft
MSFT
|
+$596M |
| 4 |
Johnson & Johnson
JNJ
|
+$307M |
| 5 |
iShares TIPS Bond ETF
TIP
|
+$256M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.25% |
| 2 | Financials | 6.72% |
| 3 | Healthcare | 6.58% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 4.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4651
Franklin Covey
FC
$246M
| $617K | ﹤0.01% |
14,115
+3,781
| +37% | +$140K |
|
|
EQRX
4652
DELISTED
EQRx, Inc. Common Stock
EQRX
| $615K | ﹤0.01% |
330,791
-83,538
| -20% | -$149K |
|
4653
Microvision
MVIS
$78.9M
| $615K | ﹤0.01% |
8,950
+3,295
| +58% | +$173K |
|
4654
Lightwave Logic
LWLG
$1.25B
| $615K | ﹤0.01% |
88,211
+42,349
| +92% | +$246K |
|
|
PEO
4655
Adams Natural Resources Fund
PEO
$725M
| $613K | ﹤0.01% |
30,625
-115
| -0.4% | -$2.25K |
|
4656
Bioceres Crop Solutions
BIOX
$22M
| $613K | ﹤0.01% |
45,864
+8,396
| +22% | +$98.4K |
|
4657
The 3D Printing ETF
PRNT
$65M
| $612K | ﹤0.01% |
26,090
-3,610
| -12% | -$80.1K |
|
4658
PMV Pharmaceuticals
PMVP
$63.5M
| $612K | ﹤0.01% |
97,719
+8,075
| +9% | +$42.3K |
|
|
SHCO
4659
CALL
DELISTED
Soho House & Co
SHCO
| $610K | ﹤0.01% |
112,500
-72,500
| -39% | -$457K |
|
4660
Capital Group US Multi-Sector Income ETF
CGMS
$5.42B
| $609K | ﹤0.01% |
23,381
+23,263
| +19,714% | +$609K |
|
4661
OneSpaWorld
OSW
$2.66B
| $608K | ﹤0.01% |
50,259
+19,499
| +63% | +$225K |
|
4662
WisdomTree Emerging Markets Local Debt Fund
ELD
$143M
| $608K | ﹤0.01% |
22,032
-1,701
| -7% | -$46.2K |
|
4663
Renaissance IPO ETF
IPO
$161M
| $607K | ﹤0.01% |
18,555
+4,302
| +30% | +$127K |
|
|
TBRG
4664
DELISTED
TruBridge
TBRG
| $607K | ﹤0.01% |
24,572
+8,575
| +54% | +$223K |
|
4665
Anika Therapeutics
ANIK
$287M
| $606K | ﹤0.01% |
23,339
+3,393
| +17% | +$90.8K |
|
4666
iShares MSCI Chile ETF
ECH
$1.06B
| $604K | ﹤0.01% |
20,708
-8,656
| -29% | -$251K |
|
4667
PUT
Amylyx Pharmaceuticals
AMLX
$2.54B
| $602K | ﹤0.01% |
27,900
| – | – |
|
4668
Applied Digital
APLD
$8.41B
| $602K | ﹤0.01% |
64,334
+25,803
| +67% | +$154K |
|
4669
Outset Medical
OM
$90.8M
| $600K | ﹤0.01% |
1,830
+67
| +4% | +$20.4K |
|
4670
Ideal Power
IPWR
$74.2M
| $598K | ﹤0.01% |
50,706
-192
| -0.4% | -$2K |
|
4671
Sinclair Inc
SBGI
$1.03B
| $598K | ﹤0.01% |
43,274
+16,228
| +60% | +$268K |
|
4672
CALL
Spotify
SPOT
$100B
| $596K | ﹤0.01% |
3,715
| – | – |
|
|
VLD
4673
DELISTED
Velo3D, Inc.
VLD
| $596K | ﹤0.01% |
7,889
+1,189
| +18% | +$82.9K |
|
|
ORAN
4674
DELISTED
Orange
ORAN
| $595K | ﹤0.01% |
51,152
+9,560
| +23% | +$116K |
|
4675
GCM Grosvenor
GCMG
$820M
| $594K | ﹤0.01% |
78,726
-5,447
| -6% | -$40.6K |
|
Similar funds
UBS Group's Q2 2023 Portfolio in Review
As of Q2 2023, UBS Group held 10,482 positions worth $296B, up 8.2% from $274B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS Group's Q2 2023 filing shows 945 new, 3,995 increased, 3,455 reduced and 1,657 closed positions. Its largest new stake was Global X Emerging Markets Great Consumer ETF: 1,048,148 shares worth $26.1M. The largest sale was UBS Group, an estimated $3.79B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2023 buy was Global X Emerging Markets Great Consumer ETF: 1,048,148 shares worth $26.1M.
- UBS Group added most to State Street Financial Select Sector SPDR ETF in Q2 2023, an estimated $456M increase.
- UBS Group's biggest Q2 2023 reduction was UBS Group, cutting an estimated $3.79B.
- UBS Group fully exited DCP Midstream, LP in Q2 2023, selling an estimated $148M.
- UBS Group's ten largest holdings make up 14% of its $296B portfolio in Q2 2023.
- UBS Group opened 945 new positions and closed 1,657 in Q2 2023.
- UBS Group's portfolio value rose 8.2% quarter-over-quarter to $296B.
Based on UBS Group's 13F filing for Q2 2023, filed 11 Aug 2023.